Raymond James & Associates’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-667
| Closed | -$32K | – | 3856 |
|
|
2022
Q3 | $32K | Sell |
667
-372
| -36% | -$17.8K | ﹤0.01% | 3696 |
|
|
2022
Q2 | $59K | Sell |
1,039
-161
| -13% | -$9.14K | ﹤0.01% | 3715 |
|
|
2022
Q1 | $97K | Sell |
1,200
-701
| -37% | -$56.7K | ﹤0.01% | 3772 |
|
|
2021
Q4 | $385K | Sell |
1,901
-204
| -10% | -$41.3K | ﹤0.01% | 3269 |
|
|
2021
Q3 | $567K | Buy |
2,105
+264
| +14% | +$71.1K | ﹤0.01% | 2965 |
|
|
2021
Q2 | $474K | Sell |
1,841
-96
| -5% | -$24.7K | ﹤0.01% | 3106 |
|
|
2021
Q1 | $581K | Buy |
1,937
+151
| +8% | +$45.3K | ﹤0.01% | 2896 |
|
|
2020
Q4 | $455K | Buy |
1,786
+8
| +0.4% | +$2.04K | ﹤0.01% | 2863 |
|
|
2020
Q3 | $442K | Sell |
1,778
-26
| -1% | -$6.46K | ﹤0.01% | 2704 |
|
|
2020
Q2 | $627K | Buy |
1,804
+94
| +5% | +$32.7K | ﹤0.01% | 2436 |
|
|
2020
Q1 | $458K | Sell |
1,710
-32
| -2% | -$8.57K | ﹤0.01% | 2474 |
|
|
2019
Q4 | $564K | Buy |
1,742
+107
| +7% | +$34.6K | ﹤0.01% | 2630 |
|
|
2019
Q3 | $447K | Sell |
1,635
-2,378
| -59% | -$650K | ﹤0.01% | 2718 |
|
|
2019
Q2 | $2.14M | Buy |
4,013
+1,152
| +40% | +$615K | ﹤0.01% | 1759 |
|
|
2019
Q1 | $1.44M | Buy |
2,861
+73
| +3% | +$36.8K | ﹤0.01% | 1980 |
|
|
2018
Q4 | $1.38M | Sell |
2,788
-1,073
| -28% | -$529K | ﹤0.01% | 1885 |
|
|
2018
Q3 | $3.53M | Sell |
3,861
-655
| -15% | -$599K | 0.01% | 1440 |
|
|
2018
Q2 | $3.31M | Sell |
4,516
-1,627
| -26% | -$1.19M | 0.01% | 1435 |
|
|
2018
Q1 | $9.79M | Sell |
6,143
-2,858
| -32% | -$4.56M | 0.02% | 790 |
|
|
2017
Q4 | $8.06M | Buy |
9,001
+474
| +6% | +$425K | 0.01% | 878 |
|
|
2017
Q3 | $3.07M | Buy |
8,527
+64
| +0.8% | +$23K | 0.01% | 1344 |
|
|
2017
Q2 | $2.48M | Buy |
8,463
+679
| +9% | +$199K | 0.01% | 1427 |
|
|
2017
Q1 | $2.74M | Sell |
7,784
-2,080
| -21% | -$732K | 0.01% | 1346 |
|
|
2016
Q4 | $1.82M | Buy |
9,864
+2,404
| +32% | +$442K | ﹤0.01% | 1549 |
|
|
2016
Q3 | $1.92M | Buy |
7,460
+1,809
| +32% | +$466K | 0.01% | 1482 |
|
|
2016
Q2 | $1.21M | Buy |
5,651
+138
| +3% | +$29.5K | ﹤0.01% | 1634 |
|
|
2016
Q1 | $1.14M | Buy |
5,513
+161
| +3% | +$33.2K | ﹤0.01% | 1613 |
|
|
2015
Q4 | $1.35M | Buy |
5,352
+215
| +4% | +$54.4K | ﹤0.01% | 1468 |
|
|
2015
Q3 | $845K | Buy |
5,137
+106
| +2% | +$17.4K | ﹤0.01% | 1679 |
|
|
2015
Q2 | $944K | Buy |
5,031
+764
| +18% | +$143K | ﹤0.01% | 1763 |
|
|
2015
Q1 | $704K | Buy |
4,267
+2,727
| +177% | +$450K | ﹤0.01% | 1865 |
|
|
2014
Q4 | $358K | Buy |
+1,540
| New | +$358K | ﹤0.01% | 2058 |
|